SynthesisBMC public health2026
Low level of selenium predicts high incidence of colorectal cancer.
Synthesis in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundTo investigate the relationship between selenium and its role in the incidence of colorectal cancer (CRC).
methodsA systematic review and meta-analysis was conducted by searching PubMed, Embase, and Web of Science databases to identify studies evaluating the association between selenium exposure and CRC risk. Studies assessing selenium by serum concentration, dietary intake, or tissue level were eligible. The relative risk (RR) and 95% confidence interval (CI) were calculated using the random effects model.
resultsA total of 16 studies were included, and the overall pooled analysis showed that higher selenium exposure was associated with a reduced risk of CRC (RR = 0.81, 95% CI = 0.72–0.91). When stratified by study design, significant inverse associations were observed in both cohort studies (RR = 0.84, 95% CI = 0.78–0.90) and case-control studies (RR = 0.76, 95% CI = 0.64–0.92). Subgroup analyses revealed significant inverse associations in European (RR = 0.81, 95% CI = 0.67–0.98) and Oceanian (RR = 0.70, 95% CI = 0.56–0.87) populations, and in colon cancer (RR = 0.81, 95% CI = 0.68–0.97) but not rectal cancer. Dietary selenium intake showed a protective effect (RR = 0.74, 95% CI = 0.63–0.86), whereas serum and toenail selenium were not significantly associated with CRC risk.
conclusionCollectively, our findings indicate that selenium sufficiency is linked to a lower risk of colorectal cancer. The results emphasize the potential role of selenium status as a modifiable nutritional factor in colorectal cancer prevention and warrant further mechanistic and interventional research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.